Found: 32
Select item for more details and to access through your institution.
Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 9, p. 2033, doi. 10.1007/s10096-021-04186-6
- By:
- Publication type:
- Article
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0790-x
- By:
- Publication type:
- Article
Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0727-4
- By:
- Publication type:
- Article
A Simple-to-Perform ifn-γ mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.919806
- By:
- Publication type:
- Article
Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.841470
- By:
- Publication type:
- Article
Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study.
- Published in:
- Hematology Reports, 2024, v. 16, n. 2, p. 283, doi. 10.3390/hematolrep16020028
- By:
- Publication type:
- Article
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 250, doi. 10.1111/bjh.19130
- By:
- Publication type:
- Article
A 16‐month‐long experience of COVID‐19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM‐TC multicentre cohort study.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1066, doi. 10.1111/bjh.18754
- By:
- Publication type:
- Article
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 274, doi. 10.1002/ajh.26442
- By:
- Publication type:
- Article
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2156, doi. 10.3390/cancers13092156
- By:
- Publication type:
- Article
Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 570, doi. 10.3390/cancers11040570
- By:
- Publication type:
- Article
Salvage haploidentical or cord‐blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM‐TC.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 1, p. 40, doi. 10.1111/ejh.13868
- By:
- Publication type:
- Article
Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 4, p. 1068, doi. 10.1002/cam4.4218
- By:
- Publication type:
- Article
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT).
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 23, doi. 10.1002/cam4.3593
- By:
- Publication type:
- Article
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 34, doi. 10.1016/j.clml.2021.07.027
- By:
- Publication type:
- Article
FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Torque Teno Virus Viral Load as a Marker of Immune Function in Allogeneic Haematopoietic Stem Cell Transplantation Recipients.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 11, p. 1292, doi. 10.3390/v12111292
- By:
- Publication type:
- Article
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0296-3
- By:
- Publication type:
- Article
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1135, doi. 10.1002/ajh.25905
- By:
- Publication type:
- Article
Impact of detectable measurable residual disease on umbilical cord blood transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1057, doi. 10.1002/ajh.25879
- By:
- Publication type:
- Article
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 282, doi. 10.1002/ajh.25714
- By:
- Publication type:
- Article
Early‐onset severe infections in allogeneic hematopoietic stem cell transplantation recipients with graft failure.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. E109, doi. 10.1002/ajh.25406
- By:
- Publication type:
- Article
Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 431, doi. 10.1002/ajh.25395
- By:
- Publication type:
- Article
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 602, doi. 10.1002/cncr.27786
- By:
- Publication type:
- Article
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 3, p. 230, doi. 10.1159/000528184
- By:
- Publication type:
- Article
Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01387-0
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01086-2
- By:
- Publication type:
- Article
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2642, doi. 10.1002/cncr.35308
- By:
- Publication type:
- Article
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 15, p. 2922, doi. 10.1002/cncr.34268
- By:
- Publication type:
- Article
Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 2, p. 209, doi. 10.1002/cncr.33255
- By:
- Publication type:
- Article
Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article